Skip to main content
European Commission logo print header

Targeting cancer vulnerabilities in acute leukemia

Publications

Putative homeostatic role of cancer driver mutations

Author(s): Avanthika Venkatachalam, Eli Pikarsky, Yinon Ben-Neriah
Published in: Trends in Cell Biology, Issue Volume 32, Issue 1, January 2022, 2022, Page(s) Pages 8-17, ISSN 0962-8924
Publisher: Elsevier BV
DOI: 10.1016/j.tcb.2021.07.002

Immunity in acute myeloid leukemia: Where the immune response and targeted therapy meet

Author(s): Avner Fink,Eric Hung,Indranil Singh,Yinon Ben-Neriah
Published in: European journal of immunology, Issue Volume 52, Issue 1, January 2022, 2022, Page(s) Pages 34-43, ISSN 1521-4141
Publisher: John Wiley & Sons, Inc
DOI: 10.1002/eji.202048945

Intellectual Property Rights

HETEROARYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE

Application/Publication number: 19 708681
Date: 2019-02-07
Applicant(s): THE HEBREW UNIVERSITY OF JERUSALEM

N1 -(4-(5-(CYCLOPROPYLMETHYL)-1 -METHYL-1 H-PYRAZOL-4-YL)PYRIDIN-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS CK1 AND/OR IRAKI INHIBITORS FOR TREATING CANCER

Application/Publication number: 18 705024
Date: 2018-01-30
Applicant(s): THE HEBREW UNIVERSITY OF JERUSALEM

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available